The Alzheimer Society Research Portal connects researchers with Canadians looking to participate in research studies. On this website, find active studies that you can participate in to help advance research on dementia.
McMaster University is conducting a study on the effects of brain stimulation in individuals aged 50 and older with dementia or memory loss. The research focuses on using repetitive transcranial magnetic stimulation (rTMS), a noninvasive technique that delivers magnetic pulses to the brain, to enhance cognitive function and balance. The goal is to extend the positive effects of brain stimulation in improving cognition and balance in individuals with dementia.
1.) Diagnosed with Dementia and/or memory loss by a clinician
2.) Exhibit adequate oral communication skills and cognitive function
3.) Walk or stand with or without personnel or assistive devices
4.) Individuals must be greater than or equal to 50 years of age
Compass-ND is a research study designed to assess individuals with different sorts of cognitive and movement changes seen in older adults. We will look at the usefulness of imaging studies, clinical assessments and biomarker tests, together with measurements of memory, thinking and daily functioning, for distinguishing these changes from each other and from healthy aging.
- are between the ages 60-90
- have up to grade 12 education
- have an individual (spouse, friend, or relative), called a “study partner,” who is willing to:
- Accompany you to the study visits
- Communicate to the study staff of changes in your health status over the period of this study
Hearing loss is the third most common chronic health condition among people 65 and older and increases the risk of social isolation, depression, communication difficulties and dementia. Dementia risk may be reduced through hearing rehabilitation, and it is critical to develop tools for identifying hearing loss and its impact on communication. The Hearing and Functioning in Everyday Life Questionnaire (HFEQ) is a measure to identify hearing loss and everyday life functioning, not yet been evaluated for people with combined hearing loss and cognitive impairment. To bridge this gap, the aim is to evaluate the HFEQ for this group. The study has a cross-sectional observational study design. Adults over 60 years, with hearing loss and with and without cognitive impairment will be recruited. Data collection will include a cognitive and hearing assessment, assessment of conversation effectiveness and efficiency, hearing and general health history and five questionnaires (HFEQ, the Life-Space questionnaire, the Social Functioning in Dementia scale, and the PROMIS anxiety and depression scales).
• Are 60 years or older
• Have hearing loss
• Experience cognitive complaints (subjective memory complaints, mild cognitive impairment, or dementia) or,
• Experience no changes in cognitive function
This randomized controlled study evaluates the efficacy of a hippocampus-targeted, computerized spatial memory intervention in older adults with Mild Cognitive Impairment (MCI). Participants (≥55 years) will be randomized to either (a) a spatial memory intervention program or (b) an active placebo. Primary outcomes are changes in memory and cognition from baseline to post-training and 6-month follow-up, assessed with standardized neuropsychological measures and validated spatial memory tasks. Secondary outcomes include everyday functioning, quality of life, perceived stress, and related psychosocial indices.
A neuroimaging sub-study acquires structural MRI and task-based fMRI to quantify hippocampal morphometry and functional recruitment; we hypothesize training-related improvements will correlate with hippocampal structural/functional change. Exploratory biomarkers (lipids, glucose/insulin for HOMA-IR, cortisol) and polygenic risk scores for dementia are obtained to control inter-individual variability and potential moderators/mediators of training response. The central hypothesis is that sustained, strategy-level engagement of hippocampus-dependent spatial memory will improve cognitive performance in MCI and yield convergent MRI biomarker signatures, supporting experience-dependent plasticity and informing scalable, non-pharmacologic interventions for delaying cognitive decline.
- Aged 55 years and above
- Have English or French as a primary language
- Received a diagnosis of Mild Cognitive Impairment (MCI)
This study will assess if an in-vehicle Driving Monitoring System can identify differences in driving behaviours between older adults who are cognitively healthy, those with mild cognitive impairment, and those with mild dementia.
Participants must:
• Be 65 years or older.
• Be cognitively healthy or have mild cognitive impairment or mild dementia.
• Have a valid General class driver’s license and still driving.
• Be fluent in English.
• Own an insured vehicle of 1998 or newer model year.
• Drive to at least 2 different locations per week.
This study explores Deep Brain Stimulation (DBS) as a potential treatment for mild Alzheimer’s disease (AD). In this study, the mild electrical stimulation is delivered to a part of the brain called the Pedunculopontine Nucleus (PPN), which helps regulate cognitive and sleep-related brain rhythms. The trial will recruit a small group of participants to evaluate the safety, feasibility, and preliminary efficacy of DBS-PPN in treating AD. The goal of this study is to see if targeting this part of the brain with DBS can help people living with mild AD improve their memory, thinking skills, and sleep quality.
Are 60 years or older
-Have a diagnosis of mild Alzheimer's Disease
-Are fluent in English
-Have a personal caregiver willing to join the study
Thinking skills (also known as cognitive functions), change from younger to older adulthood. In this study we are investigating how these shifting architectures of cognition and brain function relate to one another, and how these brain and cognitive changes impact decision-making in younger and older adults.
You may qualify to participate if you are: 1) 60 years of age or older, 2) right-handed, 3) in good health, 4) and have normal or corrected-to-normal vision. Participation will involve completing cognitive tasks, questionnaires, and non-invasive brain measurements using MRI. If you are interested in participating in this study, please contact [email protected]
You are eligible to participate if you:
- Are aged 60 years or older
- Are right-handed
- Are cognitively healthy
- Are able to come in-person to our site, located at the Montreal Neurological Institute
- Have no metal in your body (e.g., pacemaker, metal plates, orthopedic devices, etc.)
- Speak English or French
This study is testing a digital reminder system for people living with dementia. The system sends alerts when daily routines change and collects feedback from caregivers. The goal is to improve the system’s design and usefulness. Results will help make reminder tools more supportive for people living with dementia and their caregivers.
You are eligible to participate if you are a person living with dementia and you:
- Have a clinical diagnosis of mild to moderate dementia
- Were diagnosed within the past 2 years
- Speak and understand English
- Are able to give informed consent
- Have internet access at home
- Are part of a caregiver-participant pair (dyad)
You are eligible to participate if you are a caregiver and you:
- Are an informal caregiver (family member or friend)
- Provide at least 30 hours of care per week to a person living with dementia
- Speak and understand English
- Are able to give informed consent
- Can participate in a home setup session and follow-up interview
We are conducting three separate studies to explore the effects of transcranial Direct Current Stimulation (tDCS) in individuals with Alzheimer’s Disease or Primary Progressive Aphasia. tDCS is a non-invasive therapy that uses low electrical currents to stimulate specific areas of the brain. Previous research has suggested that tDCS can improve symptoms such as language difficulties and may help slow the progression of Alzheimer’s.
Our studies aim to investigate these effects in different contexts, including language therapy and overall mental abilities. Upon completion, participants will receive their study results to help guide their decisions about whether tDCS could be part of a long-term therapy plan.
Person living with Alzheimer's disease
Follow us: